LifeVantage Co. (NASDAQ:LFVN - Get Free Report)'s share price crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $7.82 and traded as high as $12.76. LifeVantage shares last traded at $12.30, with a volume of 91,453 shares.
LifeVantage Trading Down 3.1 %
The firm has a market cap of $151.40 million, a price-to-earnings ratio of 43.93 and a beta of 0.84. The company has a 50 day moving average of $9.74 and a 200 day moving average of $7.82.
LifeVantage (NASDAQ:LFVN - Get Free Report) last released its quarterly earnings results on Wednesday, August 28th. The company reported $0.14 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.21 by ($0.07). LifeVantage had a net margin of 1.47% and a return on equity of 27.85%. The firm had revenue of $48.93 million during the quarter.
LifeVantage Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 17th. Stockholders of record on Monday, September 9th were issued a $0.04 dividend. This represents a $0.16 annualized dividend and a dividend yield of 1.34%. The ex-dividend date of this dividend was Monday, September 9th. LifeVantage's payout ratio is 57.14%.
Hedge Funds Weigh In On LifeVantage
Several hedge funds have recently modified their holdings of the stock. Ritholtz Wealth Management grew its holdings in LifeVantage by 62.0% during the third quarter. Ritholtz Wealth Management now owns 28,666 shares of the company's stock worth $346,000 after purchasing an additional 10,974 shares during the period. Renaissance Technologies LLC grew its holdings in LifeVantage by 2.1% during the second quarter. Renaissance Technologies LLC now owns 855,118 shares of the company's stock worth $5,490,000 after purchasing an additional 17,300 shares during the period. Hantz Financial Services Inc. bought a new position in LifeVantage during the second quarter worth about $91,000. Hillsdale Investment Management Inc. bought a new position in LifeVantage during the first quarter worth about $76,000. Finally, Acadian Asset Management LLC grew its holdings in LifeVantage by 2.8% during the first quarter. Acadian Asset Management LLC now owns 228,088 shares of the company's stock worth $1,378,000 after purchasing an additional 6,121 shares during the period. Institutional investors own 35.32% of the company's stock.
About LifeVantage
(
Get Free Report)
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.
Recommended Stories
Before you consider LifeVantage, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and LifeVantage wasn't on the list.
While LifeVantage currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.